Validation of Novaprep(®) HQ+ liquid-based cytology medium for high-risk human papillomavirus detection by hc2.
Fiche publication
Date publication
janvier 2016
Journal
Infectious agents and cancer
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PRETET Jean-Luc, Dr LAUNAY Sophie
Tous les auteurs :
Guenat D, Launay S, Riethmuller D, Mougin C, Prétet JL
Lien Pubmed
Résumé
Preanalytical conditions determine the reliability and validity of bioassays. Therefore, the analytic performances of biological tests need to be determined when preanalytical steps differ from those recommended by the manufacturer. The objective of the study was to assess the analytic performance of the hc2 test for the detection of high-risk HPV DNA from cells stored in the new Novaprep® HQ+ medium.
Mots clés
HPV testing, Hybrid capture 2, Liquid based cytology, Papillomavirus, Validation
Référence
Infect. Agents Cancer. 2016 ;11:41